CA-125 and RECIST: Key Insights in Ovarian Cancer
Recent advancements in the treatment of ovarian cancer have increasingly focused on understanding the recurrent patterns of the disease and ...
Tag: PARP inhibitors
Organoids Forecast Chemotherapy, PARP Inhibitor Outcomes in Ovarian Cancer
In a groundbreaking study that could reshape the treatment landscape for advanced ovarian cancer, researchers have successfully utilized patient-derived organoids ...
New Blood Test Paves the Way for More Effective Ovarian Cancer Treatments
Every year, more than 300,000 women worldwide receive the devastating diagnosis of ovarian cancer, a disease notorious for its complexity ...
Optimized Tumor Therapy: Phase I Trial of Gapped Scheduling
In a groundbreaking development that could redefine cancer therapy, researchers have unveiled a novel approach to delivering topoisomerase I (top1) ...
Ovarian cancer discovery: targetable variant RAD51D found in Chinese patients
Researchers from BGI Genomics and Fudan University published new findings on OV among Chinese patients in JCO Global Oncology. The ...
